September 19, 2017 — 12:00 pm and 7:00 pm ET
The Role of the Nurse Practitioner in Optimizing Insulin Therapy: Promoting Partnerships in Care
Faculty PresenterGail L. Prater, CRNP, BC-ADM, CDE
Diabetes Nurse Practitioner
Veterans Affairs Medical Center
Endocrinology/Primary Care Clinic
Activity OverviewThis activity will bring nurse practitioners up-to-date on the latest available and emerging options in basal insulin therapy, especially biosimilar insulin. To help nurse practitioners address the unmet needs of patients in this area, expert faculty will discuss common barriers to the initiation of and adherence to insulin therapy, strategies to overcome these barriers, especially addressing financial considerations, as well as implementing DMSE/S algorithm of care for improved patient outcomes. A concluding discussion will present evidence-based strategies for integrating the latest in insulin formulations into an overall diabetes management program designed to improve glycemic control; reduce risk of hypoglycemia; and make insulin therapy more convenient, manageable, and effective.
Educational ObjectivesUpon completion of this educational activity, participants will be able to:
- Identify patients with type 2 diabetes mellitus (T2DM) who may benefit from the addition of basal insulin to their management strategy
- Articulate the role of the nurse practitioner in implementing diabetes self-management education and support (DMSE/S) algorithm of care
- Evaluate the pharmacologic features of traditional and newer basal insulin formulations, especially biosimilar insulins
- Assess the evidence for biosimilar insulins with respect to clinical efficacy, safety, and tolerability
- Describe how to implement a collaborative team-based approach to patient care for individuals with T2DM
|About This CE Activity|
|Target Audience||Length of Webinar|
|Nurse Practitioners||1 hour|
How to Obtain Credit
To receive credit, participants must complete the online pre-assessment questions, view the webinar in its entirety, and complete the post-assessment and activity evaluation form. Once this is done, participants can request their credit.
This activity is jointly provided by Global Education Group and PER®, LLC.
This activity has been planned and implemented in accordance with the accreditation Standards of the American Association of Nurse Practitioners (AANP) through joint providership of Global Education Group and (PER). Global Education Group is accredited by the American Association of Nurse Practitioners as an approved provider of nurse practitioner continuing education. Provider number: 1561024. This activity is approved for 1.0 contact hour(s) which includes 0.0 hour(s) of pharmacology.
Activity ID #2335L-1.
This activity was planned in accordance with AANP CE Standards and Policies.
For information about the approval of this program, please contact Global at 303-395-1782 or email@example.com